Science
Mechanism of Action
This extract operates through a dual-action pathway: it inhibits Matrix Metalloproteinase-9 (MMP-9) to prevent the breakdown of the dermal matrix and maintain capillary strength, which minimizes blood pigment leakage. Simultaneously, its complex polysaccharide fractions create a breathable protective film that locks in hydration and accelerates barrier repair.
Research
Clinical Evidence
High confidence3%
Key findings
- 01 A 28-day clinical trial at 3% concentration demonstrated a 9% reduction in dark circle color intensity and an 11% reduction in total surface area.
- 02 Studies at 1-5% show significant improvement in skin barrier function and a measurable decrease in Trans-Epidermal Water Loss (TEWL).
Transparency
Dusting Analysis
Due to its high efficacy in clinical trials at 3%, many formulations include it at levels below 1% for marketing claims. To achieve measurable vascular strengthening and barrier repair, concentrations should remain between 1% and 3%.
The Formula
Formulation
Stability
Heat-sensitive protein structure; must be incorporated during the cool-down phase below 40°C to maintain biological activity.
Synergies
- Caffeine
- Vitamin K
- Ceramides
- Hyaluronic Acid
Conflicts
- Extreme pH levels (>8.0 or <3.5)
- High electrolyte concentrations
Safety
Safety Profile
Generally recognized as safe within the broader category of quinoa derivatives; no evidence of systemic toxicity or irritancy at therapeutic levels.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A highly effective, multi-functional botanical for formulations targeting under-eye vascularity and compromised skin barriers.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources